Hospital Universitario Infanta Leonor — Clinical Trial Site

136 Registered trials

52 Currently recruiting

Organisation

Hospital Universitario Infanta Leonor

Location

Madrid, Spain

Identifier

ORG-100041540

Address

Avenida Gran Via Del Este 80, 28031, Spain

Departments

#9104: Hematología
10008 : Gastroenterologia
7001: Hematología
7005_Pneumology
7512 Rheumatology
Allergology
Allergy
Aparato Digestivo
Cirugía general
Departamento de dermatologia
Dermatologia
Dermatology
Dermatology department
Digestive
Digestivo
Farmacia
Gastroenterology
Haematology
hematologia
hematologia y hematoterapia
Hematology
Hematology and Hemotherapy
Hematology Dept
Hematology Unit
Infectious disease
Infectious Diseases
Intensive Care Unit
Intensive Medicine
Internal Medicine
Internal Medicine department-Infectious diseases
Internal medicine service
Medical Oncology
Medicina Interna
Mori
N/A
NA
Nefrology
Nephrology
Neumología
Neumology
Neurology
Oncology
Oncology Department
Oncology Service
Orthopedic Surgery and Traumatology Service (Knee Unit)
Pediatria
Pneumologist
Pneumology
Pneumology Department
Psychiatry
Psyquiatry
Pulmonology
Reumathology
Reumatología
Rheumatology
Rheumatology Department
Servicio de Dermatologia
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Medicina Interna
Servicio de Neumologia

Clinical trials at this site (136)

Search interface

Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir A… Ended

2024-511951-16-00 HIV 6 2022-08-30
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on… Ended

2023-509569-19-00 venous thromboembolism (VTE) 10 2022-08-10
Clinical trial developed at various hospitals where each patient randomly receive in parallel groups either placebo or treatment. Nor patien… Ended

2024-519527-14-00 Allergic rhinoconjunctivitis 5 2022-06-09
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disea… Ended

2023-504156-10-00 Plaque Psoriasis. 5 2021-08-13
A study of GSK3511294 (Depemokimab) in participants who were previously enrolled in 206713 or 213744; Open-Label Extension Ended

2023-505203-23-01 Severe asthma with an eosinophilic phenotype 5 2021-07-26
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
Study of Atezolizumab plus chemotherapy plus chemo-radiotherapy and Atezolizumab maintenance therapy in non-resectable non-small cell lung c… Ended

2024-514803-33-00 Non-small cell lung cancer (NSCLC) 4 2021-06-16
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
"A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with … Ended

2023-505787-11-00 Severe and inadequately controlled asthma 5 2021-04-29
Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGROLT) Ended

2023-509801-59-00 Alopecia areata 5 2020-07-09
A Phase 4 study to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged release (SPD503) in Children and Adolescents aged 6 … Ended

2022-502630-71-00 Attention-deficit/hyperactivity disorder (ADHD) 6 2019-11-20
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 Moderate and Severe Atopic Dermatitis 5 2019-01-09
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
A study of Ibrutinib in combination with Rituximab versus Placebo in combination with Rituximab in treatment of patients with Follicular Lym… Ended

2023-507271-21-00 Follicular Lymphoma 5 2017-04-11
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 Reversal of anticoagulation effect in patients on a FXa 5